查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732819

監管事務外包市場－全球產業規模、佔有率、趨勢、機會和預測，按服務、類別、公司規模、適應症、產品階段、最終用途、地區和競爭細分，2020-2030 年預測

Regulatory Affairs Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Category, By Company Size, By Indication, By Product Stage, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球監管事務外包市場價值為 68.4 億美元，預計到 2030 年將達到 119.4 億美元，複合年成長率為 9.73%。市場擴張主要得益於研發力度的加大以及臨床試驗申請和產品註冊數量的增加。此外，旨在控制藥品成本的監管措施正在產生經濟壓力，鼓勵生命科學公司將監管職能外包。新冠疫情進一步加速了這一趨勢，因為疫苗的緊急研發凸顯了簡化監管流程的重要性。隨著全球化的持續發展，進入國際市場的公司面臨著複雜的監管標準網路，這促使它們更加依賴外部專業知識來有效地滿足合規要求。這種需求在新興市場尤其強烈，因為這些市場的營運成本較低，監管環境對擴張的吸引力也越來越大。

市場概覽
預測期 2026-2030
2024年市場規模 68.4億美元
2030年市場規模 119.4億美元
2025-2030 年複合年成長率 9.73%
成長最快的領域 法律代表
最大的市場 亞太地區

關鍵市場促進因素

生物製藥和醫療器材公司的全球化

主要市場挑戰

資料安全和隱私問題

主要市場趨勢

監管流程的技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球監理事務外包市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按服務（監管諮詢、法律代理、監管寫作和出版、產品註冊和臨床試驗申請、監管提交、監管營運、其他服務）
    • 按類別（藥品、醫療器材）
    • 依公司規模（小型公司、中型公司、大型公司）
    • 按適應症（腫瘤科、神經科、心臟科、免疫科、其他適應症）
    • 依產品階段（臨床前、臨床、上市前核准）
    • 依最終用途（醫療器材公司、製藥公司、生技公司）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
  • 按服務
  • 按類別
  • 按公司規模
  • 按適應症
  • 按產品階段
  • 按最終用途

第6章：北美監理事務外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲監理事務外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區監理事務外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲監理事務外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲監理事務外包市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球監理事務外包市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Accell Clinical Research, LLC.
  • Genpact Ltd.
  • CRITERIUM, INC.
  • Promedica International.
  • WuXi AppTec Co Ltd.
  • Medpace Inc.
  • Charles River Laboratories Inc.
  • ICON plc.
  • Covance, Inc.
  • Parexel International Corporation.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15258

The Global Regulatory Affairs Outsourcing Market was valued at USD 6.84 billion in 2024 and is anticipated to reach USD 11.94 billion by 2030, growing at a CAGR of 9.73%. Market expansion is primarily driven by increased R&D efforts and a rising number of clinical trial applications and product registrations. Additionally, regulatory measures aimed at controlling drug costs are generating economic pressures that encourage life sciences companies to outsource regulatory functions. The COVID-19 pandemic further accelerated this trend, as the urgent development of vaccines underscored the importance of streamlined regulatory processes. As globalization continues, companies entering international markets face a complex web of regulatory standards, prompting greater reliance on external expertise to navigate compliance efficiently. This demand is especially strong in emerging markets where operational costs are lower and regulatory environments are increasingly attractive for expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.84 Billion
Market Size 2030USD 11.94 Billion
CAGR 2025-20309.73%
Fastest Growing SegmentLegal Representation
Largest MarketAsia Pacific

Key Market Drivers

Globalization of Biopharmaceutical and Medical Device Companies

The expansion of biopharmaceutical and medical device companies into international markets is a major driver behind the growth of regulatory affairs outsourcing. Each new market introduces unique compliance requirements, demanding specialized regulatory knowledge. Outsourcing helps companies manage these challenges efficiently and cost-effectively. Emerging regions such as Asia Pacific, Latin America, and the Middle East & Africa are particularly appealing due to lower development costs, skilled labor availability, and favorable regulatory climates. For instance, infrastructure investments like B. Braun's five new facilities in Malaysia and Flex Ltd.'s site in India reflect the trend of companies expanding regionally while leveraging outsourced regulatory expertise to ensure compliance.

Key Market Challenges

Data Security and Privacy Concerns

Security and privacy of sensitive regulatory information are critical challenges in this market. As outsourcing increases, so does the risk of data breaches and cyberattacks. The growing use of digital platforms-such as electronic Common Technical Document (eCTD) submissions and digital IND safety reporting-amplifies vulnerabilities. Additionally, mergers and acquisitions within the healthcare sector can expose organizations to greater cybersecurity threats due to the volume and sensitivity of exchanged data, posing a significant risk to business continuity and regulatory compliance.

Key Market Trends

Technological Advancements in Regulatory Processes

Technological progress is reshaping regulatory affairs outsourcing, introducing tools that enhance transparency, speed, and collaboration. Regulatory Information Management Systems (RIMS) are streamlining submission tracking and compliance monitoring. Cloud-based platforms enable real-time interaction between clients and service providers, improving operational efficiency. Furthermore, artificial intelligence (AI) and machine learning are being used to automate administrative tasks like data entry and document processing, allowing regulatory professionals to focus on strategic functions. These technologies are optimizing regulatory workflows, making it easier for companies to meet global compliance standards swiftly and accurately.

Key Market Players

  • Accell Clinical Research, LLC.
  • Genpact Ltd.
  • CRITERIUM, INC.
  • Promedica International.
  • WuXi AppTec Co Ltd.
  • Medpace Inc.
  • Charles River Laboratories Inc.
  • ICON plc.
  • Covance, Inc.
  • Parexel International Corporation.

Report Scope:

In this report, Global Regulatory Affairs Outsourcing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Regulatory Affairs Outsourcing Market, By Service:

  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product registration & clinical trial applications
  • Regulatory Submissions
  • Regulatory Operations
  • Other services

Regulatory Affairs Outsourcing Market, By Category:

  • Pharmaceutical
  • Medical Device

Regulatory Affairs Outsourcing Market, By Company Size:

  • Small Companies
  • Medium Companies
  • Large Companies

Regulatory Affairs Outsourcing Market, By Indication:

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Other Indications

Regulatory Affairs Outsourcing Market, By Product Stage:

  • Preclinical
  • Clinical
  • Premarket Approval

Regulatory Affairs Outsourcing Market, By End Use:

  • Medical Device Companies
  • Pharmaceutical Companies
  • Biotechnology Companies

Regulatory Affairs Outsourcing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Regulatory Affairs Outsourcing Market.

Available Customizations:

Global Regulatory Affairs Outsourcing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Regulatory Affairs Outsourcing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 5.2.2. By Category (Pharmaceutical, Medical Device)
    • 5.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 5.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 5.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 5.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 5.2.7. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.8. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Service
  • 5.3.2 By Category
  • 5.3.3 By Company Size
  • 5.3.4 By Indication
  • 5.3.5 By Product Stage
  • 5.3.6 By End Use

6. North America Regulatory Affairs Outsourcing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 6.2.2. By Category (Pharmaceutical, Medical Device)
    • 6.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 6.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 6.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 6.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Regulatory Affairs Outsourcing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Category
        • 6.3.1.2.3. By Company Size
        • 6.3.1.2.4. By Indication
        • 6.3.1.2.5. By Product Stage
        • 6.3.1.2.6. By End Use
    • 6.3.2. Canada Regulatory Affairs Outsourcing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Category
        • 6.3.2.2.3. By Company Size
        • 6.3.2.2.4. By Indication
        • 6.3.2.2.5. By Product Stage
        • 6.3.2.2.6. By End Use
    • 6.3.3. Mexico Regulatory Affairs Outsourcing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Category
        • 6.3.3.2.3. By Company Size
        • 6.3.3.2.4. By Indication
        • 6.3.3.2.5. By Product Stage
        • 6.3.3.2.6. By End Use

7. Europe Regulatory Affairs Outsourcing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 7.2.2. By Category (Pharmaceutical, Medical Device)
    • 7.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 7.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 7.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 7.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Regulatory Affairs Outsourcing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Category
        • 7.3.1.2.3. By Company Size
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By Product Stage
        • 7.3.1.2.6. By End Use
    • 7.3.2. Germany Regulatory Affairs Outsourcing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Category
        • 7.3.2.2.3. By Company Size
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By Product Stage
        • 7.3.2.2.6. By End Use
    • 7.3.3. United Kingdom Regulatory Affairs Outsourcing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Category
        • 7.3.3.2.3. By Company Size
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By Product Stage
        • 7.3.3.2.6. By End Use
    • 7.3.4. Italy Regulatory Affairs Outsourcing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Category
        • 7.3.4.2.3. By Company Size
        • 7.3.4.2.4. By Indication
        • 7.3.4.2.5. By Product Stage
        • 7.3.4.2.6. By End Use
    • 7.3.5. Spain Regulatory Affairs Outsourcing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Category
        • 7.3.5.2.3. By Company Size
        • 7.3.5.2.4. By Indication
        • 7.3.5.2.5. By Product Stage
        • 7.3.5.2.6. By End Use

8. Asia-Pacific Regulatory Affairs Outsourcing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 8.2.2. By Category (Pharmaceutical, Medical Device)
    • 8.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 8.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 8.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 8.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Regulatory Affairs Outsourcing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Category
        • 8.3.1.2.3. By Company Size
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By Product Stage
        • 8.3.1.2.6. By End Use
    • 8.3.2. India Regulatory Affairs Outsourcing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Category
        • 8.3.2.2.3. By Company Size
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By Product Stage
        • 8.3.2.2.6. By End Use
    • 8.3.3. Japan Regulatory Affairs Outsourcing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Category
        • 8.3.3.2.3. By Company Size
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By Product Stage
        • 8.3.3.2.6. By End Use
    • 8.3.4. South Korea Regulatory Affairs Outsourcing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Category
        • 8.3.4.2.3. By Company Size
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By Product Stage
        • 8.3.4.2.6. By End Use
    • 8.3.5. Australia Regulatory Affairs Outsourcing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Category
        • 8.3.5.2.3. By Company Size
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By Product Stage
        • 8.3.5.2.6. By End Use

9. South America Regulatory Affairs Outsourcing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 9.2.2. By Category (Pharmaceutical, Medical Device)
    • 9.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 9.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 9.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 9.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Regulatory Affairs Outsourcing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Category
        • 9.3.1.2.3. By Company Size
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By Product Stage
        • 9.3.1.2.6. By End Use
    • 9.3.2. Argentina Regulatory Affairs Outsourcing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Category
        • 9.3.2.2.3. By Company Size
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By Product Stage
        • 9.3.2.2.6. By End Use
    • 9.3.3. Colombia Regulatory Affairs Outsourcing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Category
        • 9.3.3.2.3. By Company Size
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By Product Stage
        • 9.3.3.2.6. By End Use

10. Middle East and Africa Regulatory Affairs Outsourcing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services)
    • 10.2.2. By Category (Pharmaceutical, Medical Device)
    • 10.2.3. By Company Size (Small Companies, Medium Companies, Large Companies)
    • 10.2.4. By Indication (Oncology, Neurology, Cardiology, Immunology, Other Indications)
    • 10.2.5. By Product Stage (Preclinical, Clinical, Premarket Approval)
    • 10.2.6. By End Use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies)
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Regulatory Affairs Outsourcing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Category
        • 10.3.1.2.3. By Company Size
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By Product Stage
        • 10.3.1.2.6. By End Use
    • 10.3.2. Saudi Arabia Regulatory Affairs Outsourcing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Category
        • 10.3.2.2.3. By Company Size
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By Product Stage
        • 10.3.2.2.6. By End Use
    • 10.3.3. UAE Regulatory Affairs Outsourcing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Category
        • 10.3.3.2.3. By Company Size
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By Product Stage
        • 10.3.3.2.6. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Regulatory Affairs Outsourcing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Accell Clinical Research, LLC.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Genpact Ltd.
  • 15.3. CRITERIUM, INC.
  • 15.4. Promedica International.
  • 15.5. WuXi AppTec Co Ltd.
  • 15.6. Medpace Inc.
  • 15.7. Charles River Laboratories Inc.
  • 15.8. ICON plc.
  • 15.9. Covance, Inc.
  • 15.10. Parexel International Corporation.

16. Strategic Recommendations

17. About Us & Disclaimer